Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole in teenagers with anorexia nervosa
NCT01082848Phase 3Unknown
- Start
- Mar 2010
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in anorexia nervosa (AN) comparing Aripiprazole with Placebo (2 arms). Primary endpoints: Eating Disorder Inventory-2 at 6 months, Eating Attitudes Test at 6 months and 1 more. Status: unknown.
02
Drugs
aripiprazole
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT01082848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01082848.